Rockstart launches accelerator for digital health startups

- Rockstart launches its first accelerator program for digital health startups, aiming to make a sustainable impact on global health systems. Working with an extensive network of mentors and investors, as well as key health institutions and organizations, the Nijmegen-based program helps startups get access to the healthcare system itself. This allows them to engage directly with patients, professionals and other stakeholders to validate their product or service. The program runs from September, applications are now open (from May 20) and can be submitted at

FICHe showcases 40 startups during eHealthWeek in Riga

- From May 11 to 13 the FICHe project joined the eHealthWeek event in Riga. Together with the 40 startups and SMEs that are selected for the second phase of the FICHe accelerator program, the FICHe project team is showcasing the results of the first part of the project. Six Dutch startups and SMEs are currently part of the project.

Product Development Partnerships III Fund

- The Product Development Partnerships III Fund (PDP III) contributes to innovation in the areas of healthcare products and technologies specifically aimed at diseases and conditions related to poverty and sexual and reproductive health and rights (SRHR).

Health~Holland Update, May 2015

- We are happy to present to you the second edition of our bimonthly news magazine, the Health~Holland Update.

Pfizer Acquires Minority Interest in AM-Pharma; Secures Option to Acquire Company

- AM‐Pharma B.V., a privately held Dutch biopharmaceutical company focused on the development of recombinant human Alkaline Phosphatase (recAP ) for inflammatory diseases, and Pfizer Inc. (NYSE: PFE) announced today that Pfizer has acquired a minority equity interest in AM-Pharma and secured an exclusive option to acquire the remaining equity in the company.

MorphoSys Acquires Peptide Therapeutic Company Lanthio Pharma

- Acquisition Adds Novel Candidates Including Pre-IND Candidate for Fibrotic Diseases to MorphoSys’s Growing Proprietary Portfolio.

Green Innovation Boost

- Meld uw innovatie aan voor de Green Innovation Boost van Greenport Holland en Topsector T&U

Abbvie buys stocks Galapagos

- Galapagos NV (Euronext: GLPG) kondigde vandaag aan dat het van plan is om, afhankelijk van markt- en andere omstandigheden, ongeveer $200 miljoen van haar gewone aandelen aan te bieden in het kader van een aandelenuitgifte, samengesteld uit een aanbieding van gewone aandelen in de vorm van American Depositary Shares (“ADSs”) en een aanbod van gewone aandelen in Europa en landen buiten de Verenigde Staten en Canada in het kader van een gelijktijdige private plaatsing. Beleggers die geen gekwalificeerde beleggers zijn onder toepasselijk recht zullen niet kunnen deelnemen aan deze private plaatsing.

5 million euros for CTMM research pearls

- Eindhoven – April 23, 2015 – The Dutch Ministry of Economic Affairs has granted 2.5 million euros to extend seven promising research projects aimed at medical innovation. The projects, which are focused at debilitating and life-threatening diseases such as breast cancer, prostate cancer and thrombosis, are part of the Dutch CTMM (Center for Translational Molecular Medicine) research programme. CTMM’s mission is to accelerate the introduction of medical innovations to patients via public-private partnerships collaborations. The companies and academic institutions involved in the seven projects will jointly contribute a matching 2.5 million euros, making a total of 5 million euros available over the next two years.

Holland Medical Guide

- Schrijf u nu in voor de Holland Medical Guide 2015 - 2016 en presenteer uw organisatie bij meer dan 5.000 contacten wereldwijd!